Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of “Hold” from Analysts
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have earned an average recommendation of “Hold” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, three have assigned a buy recommendation and […]
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have earned an average recommendation of “Hold” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, three have assigned a buy recommendation and […]
